Us-Bancorp-De

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-08
Total Holdings
7,736
Total Value
21654102517
Accession Number
0000036104-25-000031
Form Type
13F-HR
Manager Name
Us-Bancorp-De
Data Enrichment
83% identified
6,441 identified1,295 unidentified

Holdings

7,736 positions • $21.7B total value
Manager:
Search and click to pin securities to the top
OMEROS CORP
Shares:17
Value:$140
% of Portfolio:0.0% ($140/$21.7B)
indie Semiconductor, Inc.
Shares:69
Value:$140
% of Portfolio:0.0% ($140/$21.7B)
Verastem, Inc.
Shares:23
Value:$139
% of Portfolio:0.0% ($139/$21.7B)
Aldeyra Therapeutics, Inc.
Shares:24
Value:$138
% of Portfolio:0.0% ($138/$21.7B)
Pagaya Technologies Ltd.
Shares:13
Value:$136
% of Portfolio:0.0% ($136/$21.7B)
Root, Inc.
Shares:1
Value:$133
% of Portfolio:0.0% ($133/$21.7B)
GYRE THERAPEUTICS, INC.
Shares:17
Value:$131
% of Portfolio:0.0% ($131/$21.7B)
25460G609
Shares:2
Value:$131
% of Portfolio:0.0% ($131/$21.7B)
CHEGG, INC
Shares:203
Value:$130
% of Portfolio:0.0% ($130/$21.7B)
Canadian Solar Inc.
Shares:15
Value:$130
% of Portfolio:0.0% ($130/$21.7B)
Neurogene Inc.
Shares:11
Value:$129
% of Portfolio:0.0% ($129/$21.7B)
ROCKET PHARMACEUTICALS, INC.
Shares:19
Value:$127
% of Portfolio:0.0% ($127/$21.7B)
Compass Therapeutics, Inc.
Shares:65
Value:$124
% of Portfolio:0.0% ($124/$21.7B)
Oric Pharmaceuticals, Inc.
Shares:22
Value:$123
% of Portfolio:0.0% ($123/$21.7B)
CASSAVA SCIENCES INC
Shares:81
Value:$122
% of Portfolio:0.0% ($122/$21.7B)
Roivant Sciences Ltd.
Shares:12
Value:$121
% of Portfolio:0.0% ($121/$21.7B)
INOVIO PHARMACEUTICALS, INC.
Shares:71
Value:$116
% of Portfolio:0.0% ($116/$21.7B)
PDF SOLUTIONS INC
Shares:6
Value:$115
% of Portfolio:0.0% ($115/$21.7B)
Spero Therapeutics, Inc.
Shares:151
Value:$109
% of Portfolio:0.0% ($109/$21.7B)
74915M100
Shares:535
Value:$108
% of Portfolio:0.0% ($108/$21.7B)